BANK OF AMERICA CORP /DE/
BankPosition in RYTM — Rhythm Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in RYTM
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$54,675,166
+$30,646,403 QoQ
Shares Held
628,667
+180.0% QoQ
Ownership
0.917%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 93.92285582033095.ToString("F0")%
Shared 0.ToString("F0")%
None 6.0771441796690455.ToString("F0")%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Derivatives in RYTM
reported options exposure · as of Dec 31, 2024CallValue
$363,870
CallShares
6,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,554,846,017 across 346 Biotechnology names. RYTM ranks #39 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in RYTM
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $54,675,166 | 628,667 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $24,028,763 | 224,484 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $23,545,814 | 233,150 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $14,037,782 | 222,152 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,919,501 | 111,752 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $363,870 | 6,500 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $5,849,236 | 104,488 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $539,617 | 10,300 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $5,566,434 | 106,250 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,779,283 | 92,043 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,814,568 | 111,114 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,211,921 | 69,870 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,527,318 | 110,243 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,310,544 | 140,118 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,416,439 | 359,666 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,750,375 | 266,153 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $5,351,020 | 218,409 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $203,812 | 49,112 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $456,362 | 39,615 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,223,894 | 122,635 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,670,284 | 204,463 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,343,293 | 119,678 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $2,264,019 | 106,442 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,680,424 | 90,159 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $6,032,493 | 278,380 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,712,322 | 256,158 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $707,865 | 46,509 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||